270 related articles for article (PubMed ID: 11108288)
1. Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation.
Ferguson CM; Schwarz EM; Reynolds PR; Puzas JE; Rosier RN; O'Keefe RJ
Endocrinology; 2000 Dec; 141(12):4728-35. PubMed ID: 11108288
[TBL] [Abstract][Full Text] [Related]
2. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
4. ATF-2 cooperates with Smad3 to mediate TGF-beta effects on chondrocyte maturation.
Ionescu AM; Schwarz EM; Zuscik MJ; Drissi H; Puzas JE; Rosier RN; O'Keefe RJ
Exp Cell Res; 2003 Aug; 288(1):198-207. PubMed ID: 12878171
[TBL] [Abstract][Full Text] [Related]
5. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
6. Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation.
Li TF; Darowish M; Zuscik MJ; Chen D; Schwarz EM; Rosier RN; Drissi H; O'Keefe RJ
J Bone Miner Res; 2006 Jan; 21(1):4-16. PubMed ID: 16355269
[TBL] [Abstract][Full Text] [Related]
7. 5-azacytidine alters TGF-beta and BMP signaling and induces maturation in articular chondrocytes.
Zuscik MJ; Baden JF; Wu Q; Sheu TJ; Schwarz EM; Drissi H; O'Keefe RJ; Puzas JE; Rosier RN
J Cell Biochem; 2004 May; 92(2):316-31. PubMed ID: 15108358
[TBL] [Abstract][Full Text] [Related]
8. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
Guh JY; Chuang TD; Chen HC; Hung WC; Lai YH; Shin SJ; Chuang LY
Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126
[TBL] [Abstract][Full Text] [Related]
9. PTHrP expression in chick sternal chondrocytes is regulated by TGF-beta through Smad-mediated signaling.
Pateder DB; Ferguson CM; Ionescu AM; Schwarz EM; Rosier RN; Puzas JE; O'Keefe RJ
J Cell Physiol; 2001 Sep; 188(3):343-51. PubMed ID: 11473361
[TBL] [Abstract][Full Text] [Related]
10. Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-beta.
Dong Y; Drissi H; Chen M; Chen D; Zuscik MJ; Schwarz EM; O'Keefe RJ
J Cell Biochem; 2005 Aug; 95(5):1057-68. PubMed ID: 15962307
[TBL] [Abstract][Full Text] [Related]
11. Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells.
Kelley TJ; Elmer HL; Corey DA
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):732-8. PubMed ID: 11726399
[TBL] [Abstract][Full Text] [Related]
12. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
He WX; Niu ZY; Zhao SL; Smith AJ
Arch Oral Biol; 2005 Nov; 50(11):929-36. PubMed ID: 16183370
[TBL] [Abstract][Full Text] [Related]
13. Lead alters parathyroid hormone-related peptide and transforming growth factor-beta1 effects and AP-1 and NF-kappaB signaling in chondrocytes.
Zuscik MJ; Pateder DB; Puzas JE; Schwarz EM; Rosier RN; O'Keefe RJ
J Orthop Res; 2002 Jul; 20(4):811-8. PubMed ID: 12168672
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
[TBL] [Abstract][Full Text] [Related]
17. Smad-Runx interactions during chondrocyte maturation.
Leboy P; Grasso-Knight G; D'Angelo M; Volk SW; Lian JV; Drissi H; Stein GS; Adams SL
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S15-22. PubMed ID: 11263661
[TBL] [Abstract][Full Text] [Related]
18. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 induced alteration of skeletal morphogenesis in vivo.
Ferguson CM; Schwarz EM; Puzas JE; Zuscik MJ; Drissi H; O'Keefe RJ
J Orthop Res; 2004 Jul; 22(4):687-96. PubMed ID: 15183422
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid stimulates chondrocyte differentiation and enhances bone morphogenetic protein effects through induction of Smad1 and Smad5.
Li X; Schwarz EM; Zuscik MJ; Rosier RN; Ionescu AM; Puzas JE; Drissi H; Sheu TJ; O'Keefe RJ
Endocrinology; 2003 Jun; 144(6):2514-23. PubMed ID: 12746314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
